Kirk Ways's most recent trade in Spruce Biosciences Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spruce Biosciences Inc | Kirk Ways | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Kirk Ways | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Kirk Ways | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 20,625 | 20,625 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Kirk Ways | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |